Paper Details

  1. Home
  2. Paper Details

Vortex keratopathy associated with ribociclib.

Author: AteşÖztürk, KaraçinCengiz, TürkelAlper, YekedüzEmre, ÖzdoğanSibel, ŞeyranErdoğan

Case ReportsIn the medical field, a report that describes in detail a unique case, an unusual medical condition, or the effect of a treatment. Provides new insights and possibilities for treatment through individual patient cases.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

This case report describes a rare side effect of vortex keratopathy in a breast cancer patient treated with ribociclib, a cyclin-dependent kinase 4/6 inhibitor.
Paper Details　
Original Abstract of the Article :
Cyclin-dependent kinases 4 and 6 (CDK4/6) inhibitors are the new generation drugs that have been started to be used in our clinical practice recently. These drugs have been shown to have better progression-free survival compared to standard therapy in patients with hormone receptor-positive (HR) and...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1177/10781552221101799

データ提供：米国国立医学図書館（NLM）

Ribociclib and Vortex Keratopathy: A Rare Side Effect

The development of [CDK4/6 inhibitors] has revolutionized breast cancer treatment, offering improved outcomes for patients with [hormone receptor-positive (HR) and human epidermal growth factor receptor 2 (HER-2)-negative breast cancer]. This case report presents a rare side effect associated with the [CDK4/6 inhibitor ribociclib], known as [vortex keratopathy]. Researchers highlight the importance of recognizing this rare but potentially vision-threatening complication, emphasizing the need for careful monitoring of patients treated with CDK4/6 inhibitors.

A Rare Side Effect of CDK4/6 Inhibitors: Vortex Keratopathy

While [CDK4/6 inhibitors] have proven effective in treating breast cancer, this case report reminds us that even with advancements in medicine, unexpected side effects can occur. The development of [vortex keratopathy] in this patient underscores the importance of ongoing research and vigilant monitoring for rare but potentially significant complications associated with new medications.

Navigating Breast Cancer Treatment

Breast cancer treatment can be complex and challenging. This case report highlights the importance of open communication with your healthcare team and being aware of potential side effects, even those that are rare. It’s essential to report any unusual symptoms promptly, allowing for timely management and prevention of serious complications.

Dr. Camel's Conclusion

Just like the desert, which can offer stunning beauty but also present unexpected challenges, the journey of breast cancer treatment can be a mix of hope and uncertainty. This case report reminds us that vigilance and open communication with healthcare providers are crucial for ensuring the best possible outcomes for patients.

Date :
  1. Date Completed 2022-12-14
  2. Date Revised 2022-12-21
Further Info :

Pubmed ID

35570741

DOI: Digital Object Identifier

10.1177/10781552221101799

Related Literature

Article Analysis
・Side Effects of ribociclib
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.